Kristeen Cherney, PhD, is a mental disabilities scholar, freelance writer, and author who specializes in topics related to mental health, disabilities, women’s health, skin health, diabetes, thyroid disease, asthma, and allergies. Her recently finished dissertation explores intersections of disability studies and literacy studies. When she’s not researching or writing with the help of her office manager pup, Kristeen enjoys getting outdoors as much as possible. Read more about her work at her website http://kristeencherney.com/.\n"},"avatar":{"title":"","width":200,"height":200,"src":"https://post.healthline.com/wp-content/uploads/2019/03/200x200_Kristeen_Cherney.png","alt":""}}],"medicalReviewers":[{"id":4081,"name":{"display":"Rebecca Barnhart, PharmD, BCPP","first":"Rebecca","last":"Barnhart, PharmD, BCPP"},"userLogin":"bbarnhart","links":{"website":"","facebook":"","linkedin":"https://www.linkedin.com/in/becky-barnhart/","twitter":"","instagram":"","tiktok":""},"link":"/reviewers/becky-barnhart-pharmd-bcpp","type":{"value":"medical_reviewer","label":"Medical Advisor"},"nid":"164645","specialties":[],"guestTitle":"","bio":{"text":"
This individual is no longer a medical reviewer in our network. The credentials and contact information reflected here may not be current.\n
Dr. Rebecca Barnhart is a board certified clinical pharmacist specializing in psychiatry and neurology, and she currently practices as an outpatient clinical pharmacist in Colorado. She has over 6 years of outpatient clinical pharmacy experience, in addition to 2 years of residency training.\n
Education\n
\n
University of Maryland School of Pharmacy, PharmD\n
University of Maryland, BS\n\n
Certifications\n
\n
Licensed Pharmacist\n
Board Certified Psychiatric Pharmacist (BCPP)\n
Pharmacogenomics Certificate \n\n
Professional Accomplishments\n
\n
Completing coursework to become a wellness coach\n
Completed both PGY1 pharmacy residency and PGY2 psychiatric pharmacy residency at the VA Eastern Colorado Health Care System in Denver, Colorado\n\n
Antidepressant medications vary, and what works for one may not work for another. Finding the right drug for you may take trial and error.
Depression is a mental health issue that starts most often in early adulthood. Itâs also more common in women. However, anyone at any age may deal with depression.
Depression affects your brain, so drugs that work in your brain may prove beneficial. Common antidepressants may help ease your symptoms, but there are many other options as well.
Each drug used to treat depression works by balancing certain chemicals in your brain called neurotransmitters. These drugs work in slightly different ways to ease your depression symptoms.
Many common drugs for depression fall into the following drug classes:
SSRIs are the most commonly prescribed class of antidepressants. An imbalance of serotonin may play a role in depression. These drugs fight depression symptoms by decreasing serotonin reuptake in your brain. This effect leaves more serotonin available to work in your brain.
In addition to treating depression, duloxetine may also relieve pain. This is important because chronic pain can lead to depression or make it worse. In some cases, people with depression become more aware of aches and pains. A drug that treats both depression and pain, such as duloxetine, can be helpful to these people.
Tetracyclic antidepressants, like Maprotiline (Ludiomil), are used to treat depression and anxiety. They also work by balancing neurotransmitters to ease symptoms of depression.
The drug in this class thatâs used to treat depression is called vilazodone (Viibryd). It works by balancing serotonin levels and other neurotransmitters.
This drug is rarely used as a first-line treatment for depression. That means itâs usually only prescribed when other medications have not worked for you or caused bothersome side effects.
Two 5-HT2 receptor antagonists, nefazodone (Serzone) and trazodone (Oleptro), are used to treat depression. These are older drugs. They alter chemicals in your brain to help depression.
MAOIs are older drugs that treat depression. They work by stopping the breakdown of norepinephrine, dopamine, and serotonin.
Theyâre more difficult for people to take than most other antidepressants because they interact with prescription drugs, nonprescription drugs, and some foods. They also canât be combined with stimulants or other antidepressants.
Other depression drugs donât fall into the typical classes. These are called atypical antidepressants. Depending on your condition, your doctor may prescribe one of these alternatives instead.
For example, olanzapine/fluoxetine (Symbyax) is an atypical antidepressant. Itâs used to treat bipolar disorder and major depression that doesnât respond to other drugs.
Ask your doctor if an alternative drug treatment is a good choice for you. They can tell you more.
Medications to treat depression generally come with side effects. The specific changes you may experience depend in part on the class of drug youâre taking.
Common side effects:
Gastrointestinal symptoms:indigestion, diarrhea, constipation, loss of appetite
Feelings of sickness: headache, dizziness, dry mouth, sweating
You may experience some, many, or none of these side effects.
Potential health risks:
Serotonin syndrome.Serotonin syndrome occurs when serotonin levels are too high, usually because of combining antidepressants that raise serotonin levels. Symptoms include confusion, muscle twitching, seizures, irregular heartbeat, or unconsciousness.
Hyponatremia.Hyponatremia (low blood sodium) is a dangerous drop in salt levels in the body, usually experienced by older adults taking antidepressants. Symptoms include headache, muscle pain, disorientation, agitation, or seizures.
Suicidal thoughts. Sometimes people, particularly younger people, think about self-harm when they first start taking antidepressants. Help is available from your doctor, crisis line, or nearest emergency room.
These health risks happen less frequently than common side effects of antidepressants. They are all serious conditions for which you can get support from a doctor or mental health professional.
In addition, research from 2017 and 2019 has looked at the off-label uses for drugs for depression. These studies state antidepressants have been prescribed for:
Antidepressants, in general, are effective for moderate to severe depression. Many people do get some relief from depression symptoms by taking antidepressants.
A number of recent analyses have looked more deeply into whether antidepressants work, and these studies support their effectiveness.
A 2018 review of trials measuring the effectiveness of 21 antidepressant medications found each of these medications works better than a placebo. The review analyzed 522 studies done between 1979 and 2016, involving a total of 116,477 people.
A 2019 paper reviewed previous studies from 1990 to June 2019 on antidepressant effectiveness. The authors noted all reviews generally showed that antidepressants were effective, but only marginally effective. They concluded antidepressant benefits are minimal and increase the risk of harmful effects. However, the paper stated that additional research is needed to confirm or dispute that there is an increased risk of harmful effects.
A 2020 data analysis also looked at previously published data on antidepressant efficacy. This study came to less optimistic conclusions about how effective antidepressants are.
The study looked at whether previous analyses underestimated the effectiveness of antidepressants, due to the use of the Hamilton Depression Rating-Scale (HDRS). With the use of an alternative measurement, the Montgomery-Asberg Depression Rating-Scale (MADRS), the researchers found the previous studies did not underestimate effectiveness. The study hypothesized that antidepressants may not in fact work well for the average person.
Researchers have also looked at the effectiveness of antidepressants on subgroups of people, such as older adults, children, and adolescents.
A 2020 review of studies involving people over the age of 65 found on average 50.7 percent of people achieved at least a 50 percent reduction in depression, based on the HDRS. This analysis looked at 44 studies with a total of 6,373 people.
A 2020 meta-analysis of previous reviews looked at the effectiveness and tolerability of antidepressants in those under the age of 18. These medications are prescribed to children and adolescents for a variety of reasons. With respect to major depressive disorder, the meta-analysis found only fluoxetine (Prozac) worked better than the placebo. The review included 34 random controlled trials involving 14 antidepressants prescribed for major depressive disorder in people under the age of 18.
You may be interested in natural options to treat your depression. Some people use these treatments instead of drugs, and some use them as an add-on treatment to their antidepressant medication.
St. Johnâs wort is an herb that some people have tried for depression. According to the National Center for Complementary and Integrative Health, the herb may have mild positive effects, or it may not work any better than placebo. This herb also causes many drug interactions that can be serious.
St. Johnâs wort interacts with many medications. The herb may reduce their effectiveness or cause negative side effects. These include:
The supplement S-adenosylmethionine (SAMe) is another natural option that some people have tried to ease their depression symptoms. SAMe may help treat joint pain, but thereâs not much support to show that it helps with depression. This treatment can also interact with prescription drugs.
When you decide taking an antidepressant is right for you, it can take time to find the right one. Each person experiences depression a bit differently, so there is no âone-size-fits-allâ medication.
You can work with your doctor to find effective and easy-to-take medication. Some factors to consider include:
Your overall health. Some antidepressants can negatively affect other aspects of your physical or mental health, so your doctor will review preexisting conditions and other health factors.
Other medications. Antidepressants can interact with other prescription medications.
Side effects. Depression medication can cause side effects that make it hard for you to manage.
Prescription cost. Affordability of medication and insurance coverage is a factor for many people.
Frequency of dose. An antidepressant works best when you take it on a regular schedule as prescribed. If this is a challenge, it may be something to consider with your doctor when choosing an antidepressant.
You may have to take a medication for 6 to 8 weeks before you start to feel the full effects, but you can start noticing some benefits within the first 2 to 4 weeks.
Some people choose to switch medications or stop taking an antidepressant. Your doctor can help you make these changes, so talk with them if you feel the drug isnât working for you. If you stop your antidepressant suddenly, it can cause serious side effects.
When it comes to treating depression, what works for one person may not work for another. Finding the right drug for your depression can take time.
If you start taking medication for your depression, it may take time to determine the therapeutic dose that works for you, and you may need to try several different medications.
Ask your doctor how long it should take for your medication to work. If your symptoms of depression havenât improved by then, talk with your doctor. They may suggest another medication that may be more effective in relieving your depression.
Â
How we reviewed this article:
Healthline has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and medical journals and associations. We only use quality, credible sources to ensure content accuracy and integrity. You can learn more about how we ensure our content is accurate and current by reading our editorial policy.
Cipriani A, et al. (2018). Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889788/
Hengartner MP, et al. (2020). Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg Depression Rating Scale, the gold standard clinician rating scale: A meta-analysis of randomised placebo-controlled trials. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043778/
Miidera H., et al. (2020). Association between the use of antidepressants and the risk of type 2 diabetes: A large, population-based cohort study in Japan. https://care.diabetesjournals.org/content/43/4/885
Wong J, et al. (2017) Off-label indications for antidepressants in primary care: Descriptive study of prescriptions from an indication based electronic prescribing system. https://www.bmj.com/content/356/bmj.j603